PCDHA9 as a candidate gene for amyotrophic lateral sclerosis.
Jie ZhongChaodong WangDan ZhangXiaoli YaoQuanzhen ZhaoXusheng HuangFeng LinChun XueYaqing WangRuojie HeXu-Ying LiQibin LiMingbang WangShaoli ZhaoShabbir Khan AfridiWen-Hao ZhouZhanjun WangYan-Ming XuZhiheng XuPublished in: Nature communications (2024)
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease. To identify additional genetic factors, we analyzed exome sequences in a large cohort of Chinese ALS patients and found a homozygous variant (p.L700P) in PCDHA9 in three unrelated patients. We generated Pcdhα9 mutant mice harboring either orthologous point mutation or deletion mutation. These mice develop progressive spinal motor loss, muscle atrophy, and structural/functional abnormalities of the neuromuscular junction, leading to paralysis and early lethality. TDP-43 pathology is detected in the spinal motor neurons of aged mutant mice. Mechanistically, we demonstrate that Pcdha9 mutation causes aberrant activation of FAK and PYK2 in aging spinal cord, and dramatically reduced NKA-α1 expression in motor neurons. Our single nucleus multi-omics analysis reveals disturbed signaling involved in cell adhesion, ion transport, synapse organization, and neuronal survival in aged mutant mice. Together, our results present PCDHA9 as a potential ALS gene and provide insights into its pathogenesis.
Keyphrases
- amyotrophic lateral sclerosis
- spinal cord
- end stage renal disease
- wild type
- ejection fraction
- high fat diet induced
- newly diagnosed
- chronic kidney disease
- copy number
- multiple sclerosis
- peritoneal dialysis
- genome wide
- prognostic factors
- spinal cord injury
- cell adhesion
- poor prognosis
- gene expression
- skeletal muscle
- risk assessment
- metabolic syndrome
- type diabetes
- adipose tissue
- binding protein
- blood brain barrier
- cord blood
- climate change